Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT

Journal of Clinical Neuroscience

Volumn 15, Issue 12, 2008, Pages 1327-1334

  Tie, Jeanne ^a   Gunawardana, Dishan H ^a   Rosenthal, Mark A ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

201Tl SPECT; High grade gliomas; Radiation necrosis

Indexed keywords

THALLIUM 201;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRRADIATION; LOG RANK TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION NECROSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; TUMOR BIOPSY; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 55249101933     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.12.008     Document Type: Article

References (38)

1. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
2. Cha S. Perfusion imaging of brain tumors. Top Magn Reson Imaging. 15 (2004) 279-289
3. Hein P.A., Eskey C.J., Dunn J.F., et al. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR 25 (2004) 201-209
4. Valk P.E., and Dillon W.P. Radiation injury of the brain. AJR 156 (1991) 689-706
5. Rock J.P., Scarpace L., Hearshen D., et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54 (2004) 1111-1119
6. Schlemmer H.P., Bachert P., Henze M., et al. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 44 (2002) 216-222
7. Lemort M., Canizares-Perez A.C., Van der Stappen A., et al. Progress in magnetic resonance imaging of brain tumors. Curr Opin Oncol 19 (2007) 616-622
8. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27 (2006) 475-487
9. Ricci P.E., Karis J.P., Heiserman J.E., et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?. AJNR Am J Neuroradiol 19 (1998) 407-413
10. Langleben D.D., and Segall G.M. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med. 41 (2000) 1861-1867
11. Kaplan W.D., Takvorian T., Korris J.H., et al. Thallium-201 brain tumor imaging: A comparative study with pathologic correlation. J Nucl Med 28 (1987) 47-52
12. 201Tl SPET in the detection of recurrent brain tumours after radiation therapy. Nucl Med Commun. 23 (2002) 1183-1190
13. Benard F., Romsa J., and Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Sem Nuc Med 33 (2003) 148-162
14. Kim K.T., Black K.L., Marciano D., et al. Thallium-201 SPECT Imaging of brain tumors: methods and results. J Nucl Med 31 (1990) 965-969
15. Ancri D., Bassett J.Y., Lonchampt M.F., et al. Diagnosis of cerebral lesions by thallium-201. Radiol 128 (1978) 417-422
16. 201Tl SPECT imaging of brain tumors. J Nucl Med 41 (2000) 5-10
17. 99mTc-HMPAO [abstract]. AJNR Am J Neuroradiol 12 (1991) 1187
18. Slizofski W.J., Krishna L., Katsetos C.D., et al. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 4 (1994) 3190-3197
19. Kline J.L., Noto R.B., and Glantz M. Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. AJNR Am J Neuroradiol 17 (1996) 1681-1686
20. 201Tl SPECT and CT in the follow-up of irradiated brain tumors. Int J Clin Oncol 9 (2004) 51-58
21. Kumar A.J., Leeds N.E., Fuller G.N., et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 21 (2000) 377-384
22. Meyerand M.E., Pipas J.M., Mamourian A., et al. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol 20 (1999) 117-123
23. Langleben D.D., and Segall G.M. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41 (2000) 1861-1867
24. 18F-fluorodeoxyglucose PET. AJR 163 (1994) 1459-1465
25. Davis W.K., Boyko O.B., Hoffman J.M., et al. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol 14 (1993) 515-523
26. Wong T.Z., van der Westhuizen G.J., and Coleman R.E. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 12 (2002) 615-626
27. Sugahara T., Korogi Y., Tomiguchgi S., et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21 (2000) 901-909
28. Covarrubias D.J., Rosen B.R., and Lev M.H. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9 (2004) 528-537
29. Dierckx R.A., Martin J.J., Dobbeleir A., et al. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumors. Eur J Nucl Med 21 (1994) 621-633
30. Cipri S., Mannino R., Ruggieri R., et al. Clinical evaluation of thallium-201 single photon emission computed tomography in equivocal neuroradiological supratentorial lesions. J Neurosurg Sci 45 (2001) 75-82
31. Ishibashi M., Taguchi A., Sugita Y., et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 36 (1995) 2201-2206
32. Higa T., Maetani S., Yoichiro K., et al. Tl-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas. Clin Nucl Med 26 (2001) 119-124
33. 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas. J Neurooncol 59 (2002) 81-90
34. Vos M.J., Hoekstra O.S., Barkhof F., et al. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol 21 (2003) 3559-3565
35. Vertosick F.T., Selker R.G., Grossman S.J., et al. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme [abstract]. Neurosurgery 34 (1994) 396
36. Black K.L., Hawkins R.A., Kim K.T., et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71 (1989) 342-346
37. Gomez-Rio M., del Valle Torres D.M., Rodriguez-Fernandez A., et al. 201-Tl SPECT in low-grade gliomas: diagnostic accuracy in differential diagnosis between tumour recurrence and radionecrosis. Eur J Nucl Med Mol Imaging 31 (2004) 1237-1243
38. Keidar Z., Israel O., and Krausz Y. SPECT/CT in tumour imaging: technical aspects and clinical applications. Semin Nucl Med 3 (2003) 205-218